Skip to main content

Frost Phillip MD Et Al's Form 4 filing

Opko Health, Inc. (OPK) · filed Sep 6, 2022

Accession no.
0001209191-22-048630
Filed
Sep 6, 2022, 7:50 AM ET
Trade date
Sep 2, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions. Open-market purchases total $214.1K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Frost Phillip MD Et AlCIK 0000898860Director, Officer (CEO & Chairman), 10% Owner
Frost Gamma Investments TrustCIK 000138089610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 2, 2022Common StockPPurchaseAcquired+6,170$2.13+$13,142.1197,162,864Indirect
Sep 2, 2022Common StockPPurchaseAcquired+600$2.14+$1,281197,163,464Indirect
Sep 2, 2022Common StockPPurchaseAcquired+721$2.14+$1,541.14197,164,185Indirect
Sep 2, 2022Common StockPPurchaseAcquired+66,919$2.14+$143,206.66197,231,104Indirect
Sep 2, 2022Common StockPPurchaseAcquired+10,340$2.15+$22,179.3197,241,444Indirect
Sep 2, 2022Common StockPPurchaseAcquired+15,250$2.15+$32,787.5197,256,694Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)